<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941013-1-00043</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4702 -->  <!-- PJG ITAG l=11 g=1 f=1 --> (c) No exemption granted pursuant to &sect;1310.14 affects the criminal liability for illegal possession or distribution of listed chemicals contained in the exempt drug product. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (d) Changes in drug product compositions: Any change in the quantitative or qualitative composition of an exempt drug product listed in paragraph (e) of this section requires a new application for exemption. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (e) In addition to the drug products listed in the compendium set forth in &sect;1310.01(f)(1)(iv)(A), the following drug products, in the form and quantity listed in the application submitted (indicated as the ``date'') are designated as exempt drug products for the purposes set forth in this section: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <TABLE>  <!-- PJG tableformat 4,L2,i1,s10,7,5,5 -->  <!-- PJG ITAG l=95 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=95 g=1 f=4 --> Exempt Drug Products Containing Ephedrine and Therapeutically Significant Quantities of Another Active Medicinal Ingredient <!-- PJG 007 0150 intable --> 1Supplier <!-- PJG 007 0150 intable --> 1Product name <!-- PJG 007 0150 intable --> 1Form <!-- PJG 007 0150 intable --> 1Date <!-- PJG 007 0152 intable -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=4 --> [Reserved] <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=4 --> IV. 21 CFR Part 1313 is proposed to be amended as follows: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=4 --> PART 1313_[AMENDED] <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=4 --> 1. The authority citation for part 1313 continues to read as follows: <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=4 --> Authority:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> 21 U.S.C. 802, 830, 871(b), 971. <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> 2. Section 1313.02 is proposed to be amended by revising paragraphs (c), (d), (h) and (i); redesignating paragraph (m) as paragraph (o) and adding new paragraphs (m) and (n) to read as follows: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;1313.02 <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Definitions. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * * <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (c) The term  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> regulated person  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> means any individual, corporation, partnership, association, or other legal entity who manufactures, distributes, imports, or exports a listed chemical, a tableting machine, or an encapsulating machine, or who acts as a broker or trader for an international transaction involving a listed chemical, a tableting machine, or an encapsulating machine. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (d) The term  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> regulated transaction  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> means: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (1) A distribution, receipt, sale, importation, exportation, or international transaction of a listed chemical, or if the Administrator establishes a threshold amount for a specific listed chemical, a threshold amount as determined by the Administrator, which includes a cumulative threshold amount for multiple transactions, of a listed chemical, except that such term does not include: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (i) A domestic lawful distribution in the usual course of business between agents or employees of a single regulated person; in this context, agents or employees means individuals under the direct management and control of the regulated person; <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (ii) A delivery of a listed chemical to or by a common or contract carrier for carriage in the lawful and usual course of the business of the common or contract carrier, or to or by a warehouseman for storage in the lawful and usual course of the business of the warehouseman, except that if the carriage or storage is in connection with the distribution, importation, or exportation of a listed chemical to a third person, this paragraph does not relieve a distributor, importer, or exporter from compliance with this part or parts 1309 and 1310 of this chapter; <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (iii) Any category of transaction or any category of transaction for a specific listed chemical or chemicals specified by regulation of the Administrator as excluded from this definition as unnecessary for enforcement of the Act; <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (iv) Any transaction in a listed chemical that is contained in a drug that may be marketed or distributed lawfully in the United States under the Federal Food, Drug, and Cosmetic Act unless_ <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (A) The drug contains ephedrine or its salts, optical isomers, or salts of optical isomers as the only active medicinal ingredient or contains ephedrine or its salts, optical isomers or salts of optical isomers and therapeutically insignificant quantities of another active medicinal ingredient (for purposes of this paragraph, the term ``therapeutically insignificant quantities'' shall apply if the product formulation (i.e., the qualitative and quantitative composition of active ingredients within the product) is not listed in any of the following compendiums: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> ( <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> 1 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> )  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> American Pharmaceutical Association (APhA) Handbook of Nonprescription Drugs; <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (2 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> )  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Drug Facts and Comparisons  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (published by Wolters Kluwer Company); or <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> ( <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> 3 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> )  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> USP DI  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (published by authority of the United States Pharmacopeial Convention, Inc.); <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> ( <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> 4 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ) Or the product is not listed in &sect;1310.15 as an exempt drug product. For drug products having formulations not found in the above compendiums, the Administrator shall determine, pursuant to a written request as specified in &sect;1310.14, whether the active medicinal ingredients are present in quantities considered therapeutically significant for purposes of this paragraph. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (B) The Administrator has determined that the drug or group of drugs is being diverted to obtain the listed chemical for use in the illicit production of a controlled substance; and <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            